Resources
38 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 9/1/2020 (updated 9/2/2021)
This toolkit is intended to give prescribers a broad overview of medication utilization management techniques and describe ways that prescribers can facilitate patient access to needed medications. It focuses on prescribed medications that are filled by retail pharmacies; it does not cover the processes for methadone or specialty pharmacy products, such as injectable or implantable medications, all of which are commonly covered by a patient’s medical benefit rather than their pharmacy benefit.
Posted 10/7/2020 (updated 9/2/2021)
This toolkit contains clinical materials targeting treatment of substance use disorder in the acute care setting.
Posted 10/12/2020 (updated 9/2/2021)
The Matrix Model is a framework for engaging stimulant(s) users in treatment and helping them achieve abstinence.
Posted 10/12/2020 (updated 9/2/2021)
The present two-fold study “Speed Limits – Harm reduction for people who use stimulants” significantly contributes to closing the gap of knowledge about which existing harm reduction interventions are effective for people who use stimulant drugs.
Posted 1/12/2021 (updated 9/2/2021)
During this webinar, Pam Baston, Technical Expert Lead with JBS International, Inc., provided practical examples of grant writing strategies and techniques from many successful proposals. This session included tips for: Reviewing the funding opportunity application, Creating the template and action list, Assembling a team & Creating responsive and competitive proposal sections
Posted 1/26/2021 (updated 9/2/2021)
This webinar was a continuation of the previously scheduled Grant Writing Strategies Webinar- Part 1. Pam Baston provided more practical examples of grant writing strategies and techniques from many successful proposals.
Posted 3/2/2021 (updated 9/2/2021)
As state policymakers confront the substance use disorder (SUD) epidemic, they require a wide range of data – often found in disparate systems – to understand its impact and craft more effective treatment programs and interventions. This report explores best practices and sources for data gathering and describes how states can help communities access and use data to support local efforts.
Posted 3/25/2021 (updated 9/2/2021)
Considerations for Addressing Neonatal Abstinence Syndrome (NAS)
Dr. Lopata, JBS NAS Technical Expert Leads, and NAS RCORP grantees from the Western Regions will discuss resources, stigma, best practices, and challenges in addressing NAS.
Posted 3/25/2021 (updated 9/2/2021)
Care Coordination: Navigating Individuals With OUD Through a Treatment and Recovery Continuum
Presenters from the Western Region will describe two innovative care coordination strategies and models from the RCORP/Rural Health Opioid Program grantee perspective.
Posted 4/19/2021 (updated 9/2/2021)
The present article reviews whether available efficacy and safety data support the pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD) in patients with concurrent substance use disorders (SUD). Arguments for and against treating adult ADHD with active SUD are discussed